Search Results - "Aguera Morales, Eduardo"

MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention by Navarrete-Pérez, Ainoa, Gómez-Melero, Sara, Escribano, Begoña Mª, Galvao-Carmona, Alejandro, Conde-Gavilán, Cristina, Peña-Toledo, Mª Ángeles, Villarrubia, Noelia, Villar, Luisa Mª, Túnez, Isaac, Agüera-Morales, Eduardo, Caballero-Villarraso, Javier

“…There is substantial evidence supporting the neuroprotective effects of the MIND diet in neurodegenerative diseases like Parkinson's and Alzheimer's. Our aim…”
Get full text

Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients-A Comprehensive Review by Gómez-Melero, Sara, Caballero-Villarraso, Javier, Escribano, Begoña Mª, Galvao-Carmona, Alejandro, Túnez, Isaac, Agüera-Morales, Eduardo

“…Multiple sclerosis (MS) is characterized by a variety of symptoms that have a major impact on quality of life (QoL) even in early stages. In addition to…”
Get full text

HIV infection and multiple sclerosis: a case with unexpected “no evidence of disease activity” status by Labella, Fernando, Acebrón, Fernando, Blanco-Valero, María del Carmen, Rodrígez-Martín, Alba, Monterde Ortega, Ángela, Agüera Morales, Eduardo

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system whose etiology remains unclear. It has been suggested that MS…”
Get full text

Identification of Therapeutic Lag in Multiple Sclerosis (1787) by Roos, Izanne, Leray, Emmanuelle, Frascoli, Federico, Casey, Romain, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Ayuso, Guillermo Izquierdo, Madueno, Sara Eichau, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Ozakbas, Serkan, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Bergamaschi, Roberto, Boz, Cavit, Cartechini, Elisabetta, Sa, Maria Jose, Terzi, Murat, Alroughani, Raed, Grand’Maison, Francois, Granella, Franco, Iuliano, Gerardo, Hupperts, Raymond, Lechner-Scott, Jeannette, Spitaleri, Daniele Litterio A., Van Pesch, Vincent, Soysal, Aysun, Prevost, Julie, Morales, Eduardo Aguera, Urtaza, Francisco Javier Olascoaga, Turkoglu, Recai, Sidhom, Youssef, Gouider, Riadh, Van Wijmeersch, Bart, Butzkueven, Helmut, Malpas, Charles, Vukusic, Sandra, Kalincik, Tomas

“…Abstract only…”
Get full text

Comparative Study between the Diagnostic Effectiveness of Brain SPECT with [ 123 I]Ioflupane and [ 123 I]MIBG Scintigraphy in Multiple System Atrophy by Villena-Salinas, Javier, Ortega-Lozano, Simeón José, Amrani-Raissouni, Tomader, Agüera-Morales, Eduardo, Caballero-Villarraso, Javier

“…Multiple system atrophy (MSA) is a neurodegenerative disease. It has a fast progression, so early diagnosis is decisive. Two functional imaging tests can be…”
Get full text

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis by Sainz de la Maza, Susana, Maurino, Jorge, Castillo-Triviño, Tamara, Borges, Mónica, Sebastián Torres, Berta, Sotoca, Javier, Alonso Torres, Ana María, Caminero, Ana B, Borrega, Laura, Sánchez-Menoyo, José L, Barrero-Hernández, Francisco J, Calles, Carmen, Brieva, Luis, Blasco, María Rosario, Dotor García-Soto, Julio, Rodríguez-Regal, Ana, Navarro-Cantó, Laura, Agüera-Morales, Eduardo, Garcés, Moisés, Carmona, Olga, Gabaldón-Torres, Laura, Forero, Lucía, Hervás, Mariona, Gómez-Ballesteros, Rocío

“…Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple…”
Get full text

Decompressive Hemicraniectomy without Evacuation of Acute Intraparenchymal Hemorrhage by Blanco-Acevedo, Cristóbal, Aguera-Morales, Eduardo, Fuentes-Fayos, Antonio C, Pelaez-Viña, Nazareth, Diaz-Pernalete, Rosa, Infante-Santos, Nazaret, Muñoz-Jurado, Ana, Porras-Pantojo, Manuel F, Ibáñez-Costa, Alejandro, Luque, Raúl M, Solivera-Vela, Juan

“…Intracerebral hemorrhages (ICHs) are prevalent, with high morbidity and mortality. We analyzed whether decompressive craniectomy (DC) without evacuation of the…”
Get full text

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study by De Brouwer, Edward, Becker, Thijs, Werthen-Brabants, Lorin, Dewulf, Pieter, Iliadis, Dimitrios, Dekeyser, Cathérine, Laureys, Guy, Van Wijmeersch, Bart, Popescu, Veronica, Dhaene, Tom, Deschrijver, Dirk, Waegeman, Willem, De Baets, Bernard, Stock, Michiel, Horakova, Dana, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra, Grammond, Pierre, Kalincik, Tomas, Alroughani, Raed, Grand'Maison, Francois, Skibina, Olga, Terzi, Murat, Lechner-Scott, Jeannette, Gerlach, Oliver, Khoury, Samia J, Cartechini, Elisabetta, Van Pesch, Vincent, Sà, Maria José, Weinstock-Guttman, Bianca, Blanco, Yolanda, Ampapa, Radek, Spitaleri, Daniele, Solaro, Claudio, Maimone, Davide, Soysal, Aysun, Iuliano, Gerardo, Gouider, Riadh, Castillo-Triviño, Tamara, Sánchez-Menoyo, José Luis, Laureys, Guy, van der Walt, Anneke, Oh, Jiwon, Aguera-Morales, Eduardo, Altintas, Ayse, Al-Asmi, Abdullah, de Gans, Koen, Fragoso, Yara, Csepany, Tunde, Hodgkinson, Suzanne, Deri, Norma, Al-Harbi, Talal, Taylor, Bruce, Gray, Orla, Lalive, Patrice, Rozsa, Csilla, McGuigan, Chris, Kermode, Allan, Sempere, Angel Pérez, Mihaela, Simu, Simo, Magdolna, Hardy, Todd, Decoo, Danny, Hughes, Stella, Grigoriadis, Nikolaos, Sas, Attila, Vella, Norbert, Moreau, Yves, Peeters, Liesbet

“…Disability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability…”
Get full text

Effect of the Mediterranean diet and probiotic supplementation in the management of mild cognitive impairment: Rationale, methods, and baseline characteristics by Cardelo, Magdalena P, Corina, Andreea, Leon-Acuña, Ana, Quintana-Navarro, Gracia M, Alcala-Diaz, Juan F, Rangel-Zuñiga, Oriol Alberto, Camargo, Antonio, Conde-Gavilan, Cristina, Carmona-Medialdea, Claudia, Vallejo-Casas, Juan A, Carmona-Asenjo, Elvira, Ochoa-Sepulveda, Juan J, Aguera-Morales, Eduardo, Delgado-Lista, Javier, Katsiki, Niki, Lopez-Miranda, José, Perez-Jimenez, Francisco, Yubero-Serrano, Elena M, Perez-Martínez, Pablo

“…Mild cognitive impairment (MCI) can progress to Alzheimer's disease (AD). When MCI is not properly controlled, the speed of deterioration can dramatically…”
Get full text

Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis? by Saposnik, Gustavo, Monreal, Enric, Medrano, Nicolas, García-Domínguez, Jose M, Querol, Luis, Meca-Lallana, Jose E, Landete, Lamberto, Salas, Elisa, Meca-Lallana, Virginia, García-Arcelay, Elena, Agüera-Morales, Eduardo, Martínez-Yélamos, Sergio, Gómez-Ballesteros, Rocío, Maurino, Jorge, Villar, Luisa M, Caminero, Ana B

“…•The capacity of serum neurofilament light chain (sNfL) measurement to accurately reflect ongoing neuro-axonal injury has sparked interest in its clinical…”
Get full text

Therapeutic Decision-making from the Perspective of Patients with Relapsing-remitting Multiple Sclerosis (P2-6.008) by Munoz, Julia Sabin, Alonso, Elisa Salas, Martín-Martínez, Jesús, Candeliere-Merlicco, Antonio, Barrero, Francisco, Torres, Ana Alonso, Sánchez-Menoyo, José Luis, Canelo, Laura Borrega, Rodríguez-Rodríguez, María, Gómez-Gutiérrez, Montserrat, Madueno, Sara Eichau, Hernández-Pérez, Miguel Ángel, Calles, Carmen, Fernández-Díaz, Eva, Carmona, Olga, Orvíz, Aida, López-Real, Ana, López-Muñoz, Pablo, Mendoza, Amelia, Morales, Eduardo Aguera, Maurino, Jorge

“…Abstract only…”
Get full text

Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study by Blanco-Ruiz, Marina, Amaya-Pascasio, Laura, de Torres Chacón, Reyes, Álvarez Soria, María Josefa, Arjona-Padillo, Antonio, Carrillo Bailén, María Magdalena, Milán Pinilla, Rodrigo, Pérez Ortega, Irene, Sánchez Rodríguez, Belén, Andrade Zumárraga, Luis, Valverde Moyano, Roberto, Payán Ortiz, Manuel, Castillo Fernández, Alba María, Del Toro Pérez, Cristina, González Bustos, Pablo, Agüera Morales, Eduardo, Sánchez López, Purificación, Hidalgo Martín, Beatriz, Roa Chamorro, Ricardo, Fernández Pérez, Javier, Mejías Olmedo, María Victoria, Martínez-Sánchez, Patricia

“…The benefits of the PCSK9 inhibitors, alirocumab and evolocumab, in lowering LDL-cholesterol and preventing major adverse cardiac events (MACE) have been…”
Get full text

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis by Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S, Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Macdonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trnený, Marek, Kozak, Tomas, van der Walt, Anneke, Butzkueven, Helmut, McCombe, Pamela, Skibina, Olga, Lechner-Scott, Jeannette, Willekens, Barbara, Cartechini, Elisabetta, Ozakbas, Serkan, Alroughani, Raed, Kuhle, Jens, Patti, Francesco, Duquette, Pierre, Lugaresi, Alessandra, Khoury, Samia J, Slee, Mark, Turkoglu, Recai, Hodgkinson, Suzanne, John, Nevin, Maimone, Davide, Sa, Maria Jose, van Pesch, Vincent, Gerlach, Oliver, Laureys, Guy, Van Hijfte, Liesbeth, Karabudak, Rana, Spitaleri, Daniele, Csepany, Tunde, Gouider, Riadh, Castillo-Triviño, Tamara, Taylor, Bruce, Sharrack, Basil, Snowden, John A, Mrabet, Saloua, Garber, Justin, Sanchez-Menoyo, Jose Luis, Aguera-Morales, Eduardo, Blanco, Yolanda, Al-Asmi, Abdullah, Weinstock-Guttman, Bianca, Fragoso, Yara, de Gans, Koen, Kermode, Allan

“…Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS). To compare the effectiveness of…”
Get more information

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis by Roos, Izanne, Malpas, Charles, Leray, Emmanuelle, Casey, Romain, Horakova, Dana, Havrdova, Eva Kubala, Debouverie, Marc, Patti, Francesco, De Seze, Jerome, Izquierdo, Guillermo, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marc, Ozakbas, Serkan, Grammond, Pierre, Zephir, Helene, Ciron, Jonathan, Maillart, Elisabeth, Moreau, Thibault, Amato, Maria Pia, Labauge, Pierre, Alroughani, Raed, Buzzard, Katherine, Skibina, Olga, Terzi, Murat, Laplaud, David Axel, Berger, Eric, Grand'Maison, Francois, Lebrun-Frenay, Christine, Cartechini, Elisabetta, Boz, Cavit, Lechner-Scott, Jeannette, Clavelou, Pierre, Stankoff, Bruno, Prevost, Julie, Kappos, Ludwig, Pelletier, Jean, Shaygannejad, Vahid, Yamout, Bassem I., Khoury, Samia J., Gerlach, Oliver, Spitaleri, Daniele L.A., Van Pesch, Vincent, Gout, Olivier, Turkoglu, Recai, Heinzlef, Olivier, Thouvenot, Eric, McCombe, Pamela Ann, Soysal, Aysun, Bourre, Bertrand, Slee, Mark, Castillo-Trivino, Tamara, Bakchine, Serge, Ampapa, Radek, Butler, Ernest Gerard, Wahab, Abir, Macdonell, Richard A., Aguera-Morales, Eduardo, Cabre, Philippe, Ben, Nasr Haifa, Van der Walt, Anneke, Laureys, Guy, Van Hijfte, Liesbeth, Ramo-Tello, Cristina M., Maubeuge, Nicolas, Hodgkinson, Suzanne, Sánchez-Menoyo, José Luis, Barnett, Michael H., Labeyrie, Celine, Vucic, Steve, Sidhom, Youssef, Gouider, Riadh, Csepany, Tunde, Sotoca, Javier, de Gans, Koen, Al-Asmi, Abdullah, Fragoso, Yara Dadalti, Vukusic, Sandra, Butzkueven, Helmut, Kalincik, Tomas

“…To evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy. This was a retrospective cohort study…”
Get full text

Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression by De Brouwer, Edward, Becker, Thijs, Moreau, Yves, Havrdova, Eva Kubala, Trojano, Maria, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Grammond, Pierre, Kuhle, Jens, Kappos, Ludwig, Sola, Patrizia, Cartechini, Elisabetta, Lechner-Scott, Jeannette, Alroughani, Raed, Gerlach, Oliver, Kalincik, Tomas, Granella, Franco, Grand'Maison, Francois, Bergamaschi, Roberto, José Sá, Maria, Van Wijmeersch, Bart, Soysal, Aysun, Sanchez-Menoyo, Jose Luis, Solaro, Claudio, Boz, Cavit, Iuliano, Gerardo, Buzzard, Katherine, Aguera-Morales, Eduardo, Terzi, Murat, Trivio, Tamara Castillo, Spitaleri, Daniele, Van Pesch, Vincent, Shaygannejad, Vahid, Moore, Fraser, Oreja-Guevara, Celia, Maimone, Davide, Gouider, Riadh, Csepany, Tunde, Ramo-Tello, Cristina, Peeters, Liesbet

“…•Temporal neural networks allow to significantly improve the prediction of disability progression in MS patients.•Disability progression can be predicted in a…”
Get full text

Delay from treatment start to full effect of immunotherapies for multiple sclerosis by Roos, Izanne, Leray, Emmanuelle, Frascoli, Federico, Casey, Romain, Brown, J William L, Horakova, Dana, Havrdova, Eva K, Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Sá, Maria José, Cartechini, Elisabetta, Boz, Cavit, Granella, Franco, Hupperts, Raymond, Terzi, Murat, Lechner-Scott, Jeannette, Spitaleri, Daniele, Van Pesch, Vincent, Soysal, Aysun, Olascoaga, Javier, Prevost, Julie, Aguera-Morales, Eduardo, Slee, Mark, Csepany, Tunde, Turkoglu, Recai, Sidhom, Youssef, Gouider, Riadh, Van Wijmeersch, Bart, McCombe, Pamela, Macdonell, Richard, Coles, Alasdair, Malpas, Charles B, Butzkueven, Helmut, Vukusic, Sandra, Kalincik, Tomas

“…In multiple sclerosis, treatment start or switch is prompted by evidence of disease activity. Whilst immunomodulatory therapies reduce disease activity, the…”
Get full text

Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial by Saver, Jeffrey L, Cordonnier, Charlotte, Steiner, Thorsten, Littauer, Ross, Lucas, Nisha, Simard, J Marc, Kimberly, W Taylor, Alexandrov, Andrei, Barlinn, Kristian, Bereczki, Daniel, Berk, Julie, Berkeley, Jennifer, Berrouschot, Joerg, Bettermann, Kerstin, Bonato, Sara, Bruno, Askiel, Cao, Wenfeng, Cardona Portela, Pedro, Cerejo, Russell, Cheng, Roger, Ching, Marilou, Chung, Lee, Clark, Jonie, Cogez, Julien, Coull, Bruce, Devlin, Thomas, Diomedi, Marina, Fernandez Sanchez, Victoria Eugenia, Ferro, José Manuel, Finocchi, Cinzia, Geng, Deqin, Gordon, Errol, Harnof, Sagi, Hayasaka, Michihiro, He, Jincai, Hemelsoet, Dimitri, Hill, Michael, Hirano, Teruyuki, Ifergane, Gal, Isayev, Yevgeniy, Jatuzis, Dalius, Jeon, Sang-Beom, Kasner, Scott, Kelly, Adam, Kerrigan, Deborah, Kim, Minjee, Kimura, Kazumi, Kimura, Naoto, Koehrmann, Martin, Kullman, Dimitri, Lago Martin, Aida, Leker, Ronen, Lioutas, Vasileious-Arsenios, Liu, Chunfeng, Liu, Wei, Longoni, Marco, Lopez, George, Martins Maia Carvalho, Fernanda, Mayer, Stephan, McGrade, Harold, Melnikova, Elena, Meyer, Brett, Miller, Chad, Murialdo, Alessandra, Muscat, Paul, Nagy, Ferenc, Nomura, Sadahiro, Olga, Samoshkina, Ouriques Martins, Sheila Cristina, Ovary, Csaba, Panczel, Gyula, Perry, Richard, Petersen, Nils, Renati, Swetha, Richard, Sébastien, Rocha, Marcelo, Roje Bedekovic, Marina, Roriz Cruz, Matheus, Santo, Gustavo, Sato, Kenichi, Schaefer, Jan-Hendrik, Shepherd, Starane, Shi, Fudong, Shimoe, Yutaka, Sibon, Igor, Silliman, Scott, Strbian, Daniel, Stretz, Hanns Christoph, Sztriha, Laszlo, Takizawa, Katsumi, Tedim Cruz, Vitor, Tomek, Ales, Toni, Danilo, Wang, Ning, Werring, David, Wilson, Laura, Xiong, Yingqiong, Xu, Jindong, Yi, Fei, Zhang, Meng

“…No treatment is available to prevent brain oedema, which can occur after a large hemispheric infarction. Glibenclamide has previously been shown to improve…”
Get full text

Person-centered Assessment in Early Alzheimer’s Disease (P1-1.Virtual) by Galende, Alberto Villarejo, Garcia-Arcelay, Elena, Pinol-Ripoll, Gerard, del Olmo-Rodriguez, Antonio, Vinuela, Felix, Rovira, Merce Boada, Franco-Macias, Emilio, Ibañez, Almudena, Riverol, Mario, Pijoan, Albert Puig, Abizanda, Pedro, Gonzalez, Rafael Arroyo, Baquero, Miquel, Feria, Inmaculada, Balasa, Mircea, Berbel, Angel, Rodriguez-Rodriguez, Eloy, Vieira, Alba, Garcia-Ribas, Guillermo, Rodrigo-Herrero, Silvia, Lleo, Alberto, Morales, Eduardo Aguera, Catalán-Flores, Carmen, Maurino, Jorge

“…Abstract only…”
Get full text

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable by Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K, Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Amato, Maria Pia, Karabudak, Rana, Grand’Maison, Francois, Khoury, Samia J, Grammond, Pierre, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Turkoglu, Recai, Altintas, Ayse, Maimone, Davide, Kermode, Allan, Shalaby, Nevin, Pesch, Vincent V, Butler, Ernest, Sidhom, Youssef, Gouider, Riadh, Mrabet, Saloua, Gerlach, Oliver, Soysal, Aysun, Barnett, Michael, Kuhle, Jens, Hughes, Stella, Sa, Maria J, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Ampapa, Radek, Petersen, Thor, Ramo-Tello, Cristina, Spitaleri, Daniele, McCombe, Pamela, Taylor, Bruce, Prevost, Julie, Foschi, Matteo, Slee, Mark, McGuigan, Chris, Laureys, Guy, Hijfte, Liesbeth V, de Gans, Koen, Solaro, Claudio, Oh, Jiwon, Macdonell, Richard, Aguera-Morales, Eduardo, Singhal, Bhim, Gray, Orla, Garber, Justin, Wijmeersch, Bart V, Simu, Mihaela, Castillo-Triviño, Tamara, Sanchez-Menoyo, Jose L, Khurana, Dheeraj, Al-Asmi, Abdullah, Al-Harbi, Talal, Deri, Norma, Fragoso, Yara, Lalive, Patrice H, Sinnige, L G F, Shaw, Cameron, Shuey, Neil, Csepany, Tunde, Sempere, Angel P, Moore, Fraser, Decoo, Danny, Willekens, Barbara, Gobbi, Claudio, Massey, Jennifer, Hardy, Todd, Parratt, John, Kalincik, Tomas

“…Abstract Geographical variations in the incidence and prevalence of multiple sclerosis have been reported globally. Latitude as a surrogate for exposure to…”
Get full text

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study by Dekeyser, Cathérine, Hautekeete, Matthias, Cambron, Melissa, Van Pesch, Vincent, Patti, Francesco, Kuhle, Jens, Khoury, Samia, Lechner Scott, Jeanette, Gerlach, Oliver, Lugaresi, Alessandra, Maimone, Davide, Surcinelli, Andrea, Grammond, Pierre, Kalincik, Tomas, Habek, Mario, Willekens, Barbara, Macdonell, Richard, Lalive, Patrice, Csepany, Tunde, Butzkueven, Helmut, Boz, Cavit, Tomassini, Valentina, Foschi, Matteo, Sánchez-Menoyo, José Luis, Altintas, Ayse, Mrabet, Saloua, Iuliano, Gerardo, Sa, Maria Jose, Alroughani, Raed, Karabudak, Rana, Aguera-Morales, Eduardo, Gray, Orla, de Gans, Koen, van der Walt, Anneke, McCombe, Pamela A, Deri, Norma, Garber, Justin, Al-Asmi, Abdullah, Skibina, Olga, Duquette, Pierre, Cartechini, Elisabetta, Spitaleri, Daniele, Gouider, Riadh, Soysal, Aysun, Van Hijfte, Liesbeth, Slee, Mark, Amato, Maria Pia, Buzzard, Katherine, Laureys, Guy

“…BackgroundIt remains unclear whether routine cerebrospinal fluid (CSF) parameters can serve as predictors of multiple sclerosis (MS) disease course.MethodsThis…”
Get full text